Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Outcomes of unexpected pregnancy during anti-hepatitis B virus therapy with adefovir dipivoxil: a report on safety and full-term infants].

Zhao KK, Zhao Y, Miao QL.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jun;20(6):476-7. Chinese. No abstract available.

PMID:
23230598
2.

[Evaluation of the safety of pregnancy initiated by chronic hepatitis B fathers while taking adefovir].

Dai WW, Li DK.

Zhonghua Gan Zang Bing Za Zhi. 2012 Jan;20(1):57-8. Chinese. No abstract available.

PMID:
22489297
3.

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Arterburn S, Xiong S, Currie G, Brosgart CL; Adefovir Dipivoxil 438 Study Group..

N Engl J Med. 2005 Jun 30;352(26):2673-81.

4.

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL; Adefovir Dipivoxil 438 Study Group..

Gastroenterology. 2006 Dec;131(6):1743-51. Epub 2006 Sep 20.

PMID:
17087951
5.

Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil.

Delaney WE 4th.

J Antimicrob Chemother. 2007 May;59(5):827-32. Epub 2007 Mar 1.

PMID:
17332007
6.
7.

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, Germanidis G, Lee SS, Flisiak R, Kaita K, Manns M, Kotzev I, Tchernev K, Buggisch P, Weilert F, Kurdas OO, Shiffman ML, Trinh H, Washington MK, Sorbel J, Anderson J, Snow-Lampart A, Mondou E, Quinn J, Rousseau F.

N Engl J Med. 2008 Dec 4;359(23):2442-55. doi: 10.1056/NEJMoa0802878.

8.

[A clinical study of adefovir dipivoxil treatment for chronic hepatitis patients with cirrhosis in their decompensation period].

Yang Q, Gong ZJ, Hu DF.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):515-9. Chinese.

PMID:
19912686
9.

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, Borroto-Esoda K, Frederick D, Rousseau F.

Hepatology. 2008 Sep;48(3):750-8. doi: 10.1002/hep.22414.

PMID:
18752330
10.

Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.

Schildgen O, Hartmann H, Gerlich WH.

Scand J Gastroenterol. 2006 Feb;41(2):245-6. No abstract available.

PMID:
16484132
11.

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL; Adefovir Dipivoxil 437 Study Group..

N Engl J Med. 2003 Feb 27;348(9):808-16.

12.

Adefovir dipivoxil: focus on its use in the treatment of chronic hepatitis B.

Baker DE.

Rev Gastroenterol Disord. 2005 Spring;5(2):89-100. Review.

PMID:
15976740
13.

[Safety and efficacy of of adefovir dipivoxil in the treatment of patients with chronic hepatitis B-related liver disease].

Pérez Roldán F, Roncero García-Escribano O, González Carro P, Villafáñez García MC, Legaz Huidobro ML.

Gastroenterol Hepatol. 2004 Aug-Sep;27(7):432-3. Spanish. No abstract available.

PMID:
15461947
14.

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL; Adefovir Dipivoxil 438 Study Group..

N Engl J Med. 2003 Feb 27;348(9):800-7. Erratum in: N Engl J Med. 2003 Mar 20;348(12):1192.

15.

Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants.

Wu IC, Shiffman ML, Tong MJ, Marcellin P, Mondou E, Frederick D, Snow-Lampart A, Sorbel J, Rousseau F, Chang TT.

Clin Infect Dis. 2008 Nov 15;47(10):1305-11. doi: 10.1086/592570.

PMID:
18840078
16.

[Efficacy of the 96-week adefovir dipivoxil therapy in patients with chronic hepatitis B].

Xu Z, Chen LB, Cao H, Shu X, Xu QH, Li G, Xie QF.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Jun;24(3):224-6. Chinese.

PMID:
21186534
17.

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Mohamadnejad M.

Arch Iran Med. 2006 Jan;9(1):90-2. No abstract available.

PMID:
16649389
18.

Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection.

Hadziyannis SJ, Papatheodoridis GV.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):475-83. Review.

PMID:
15482214
19.

Adefovir dipivoxil in chronic hepatitis B infection.

Yuen MF, Lai CL.

Expert Opin Pharmacother. 2004 Nov;5(11):2361-7. Review.

PMID:
15500383
20.

Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B.

Peters MG, Hann Hw Hw, Martin P, Heathcote EJ, Buggisch P, Rubin R, Bourliere M, Kowdley K, Trepo C, Gray Df Df, Sullivan M, Kleber K, Ebrahimi R, Xiong S, Brosgart CL.

Gastroenterology. 2004 Jan;126(1):91-101.

PMID:
14699491

Supplemental Content

Support Center